Search

Achieving health equity in populations with congenital heart disease (CHD) requires recognizing existing disparities throughout the lifespan that negatively and disproportionately impact specific groups of individuals. These disparities occur at individual, institutional, or system levels and often result in increased morbidity and mortality for marginalized or racially minoritized populations (population subgroups (e.g., ethnic, racial, social, religious) with differential power compared to those deemed to hold the majority power in the population). Creating actionable strategies and solutions to address these health disparities in patients with CHD requires critically examining multilevel factors and health policies that continue to drive health inequities, including varying social determinants of health (SDOH), systemic inequities, and structural racism. In this comprehensive review article, we focus on health equity solutions and health policy considerations for minoritized and marginalized populations with CHD throughout their lifespan in the United States. We review unique challenges that these populations may face and strategies for mitigating disparities in lifelong CHD care. We assess ways to deliver culturally competent CHD care and to help lower-health-literacy populations navigate CHD care. Finally, we review system-level health policies that impact reimbursement and research funding, as well as institutional policies that impact leadership diversity and representation in the workforce.

The short alkyl chain of N‐octylamine was demonstrated to be able to transfer silver nanoparticles (AgNPs) from the aqueous to toluene phase with a narrow average size lower than 10 nm via ligand exchange between N‐octylamine and the sodium citrate used as a reducing and stabilizing agent during AgNPs synthesis. Surface plasmon analysis by UV‐visible spectroscopy showed that the N‐octylamine concentration significantly influences the concentration and stability of AgNPs transferred to the toluene phase and the time required for such transfer. Then, the transferred silver nanoparticles were deposited on a polydimethylsiloxane (PDMS) substrate by drop‐casting (PDMS‐T‐50‐D) or immersion (PDMS‐T‐50‐I). XPS analysis demonstrated that the AgNPs are deposited at lower than 0.02 % atomic percentages through both deposition methods. The Raman signal and the noise by fluorescence signal were shown to be significantly influenced by the AgNPs deposition method on PDMS film. The trace content of AgNPs on the flexible PDMS films on both PDMS‐T‐50‐D and PDMS‐T‐50‐I substrates can eliminate the fluorescence signal of the analyte; however, only the PDMS‐T‐50‐I substrate demonstrated a remarkable SERS‐enhanced signal. These results could significantly contribute to the design of new flexible and removable SERS substrates with ultra‐low contents of noble metal NPs. [ABSTRACT FROM AUTHOR]

Copyright of Nueva Revista del Pacífico is the property of Universidad de Playa Ancha de Ciencias de la Educacion and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)

Two strategies were considered for the synthesis of 2,3-unsaturated O-glucosyl-1,2,3-triazoles. The first, involving reaction between tri-O-acetyl-D-glucal and triazole alcohols gave no stereoselectivity. A second strategy provided 2,3-unsaturated O-glycosides from glycals and alkynols through a Ferrier rearrangement; this method, employing montmorillonite K-10 doped with iron(III) chloride hexahydrate in dichloromethane afforded new glycosides in good to excellent yields within short times and with high a-stereoselectivities. Subsequently, the glucosides were coupled with 2-azido-1,4-naphthoquinone to produce a new series of 1,2,3-1H-triazolyl O-glucoside derivatives through a click reaction. [ABSTRACT FROM AUTHOR]